Asia Pacific Small Animal Imaging (In-vivo) Market By Component (Micro-MRI, Optical Imaging, Nuclear Imaging), Application (Monitoring treatment, Bio-distribution, Cancer cell detection, Biomarkers, Longitudinal studies, Epigenetics)
Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
Get in-depth analysis of the COVID-19 impact on the Asia Pacific Small Animal Imaging (In-vivo) Market
Asia Pacific small animal imaging (in-vivo) market is expected to grow at CAGR of 13% from 2016 to 2022. The growth of the small animal imaging (in-vivo) market is driven due to multi-functional pre-clinical imaging, investments by clinical research organizations (CROs) in pre-clinical studies, a growing number of pharmaceutical and research-based organizations and technical breakthroughs such as high-resolution MRI with other imaging modalities.
Stringent government regulations, inadequate reimbursement policies, accuracy and a high cost of the devices are the factors that would hinder the market growth during the forecast period. Rising R&D investments by pharmaceutical companies is a result of a rapidly changing industry landscape, specifical expansion of the biotechnology segment. Innovative product launches would be witnessed due to vertical competition in the industry.
A growing number of pharmaceutical and research organizations for the diagnosis of diseases, the growing purchasing power of the end user in the underdeveloped and developing regions would cumulatively add to the growth of the markets. The report highlights the adoption of Small Animal Imaging (In-vivo) Market in the Asia Pacific. Based on the Technology, the Asia Pacific Small Animal Imaging (In-vivo) Market is segmented into Micro-MRI, Optical Imaging, Nuclear Imaging and Others (Micro-Ultrasound and micro-CT) segment.
Based on the Application, the market is bifurcated into Monitoring treatment, Bio-distribution, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics segments. The countries included in the report are China, Japan, India, South Korea, Singapore, Malaysia and Rest of Asia Pacific. Key players profiled in the report include Thermo Fisher Scientific Inc., Mediso Medical Imaging Systems, Promega Corporation, Miltenyi Biotech GmbH, Bruker Corporation, PerkinElmer Inc., Aspect Imaging Ltd., Siemens AG, and Fujifilm Holdings Corporation.